Seah, J.-A. (2013) “Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process”, Canadian Urological Association Journal, 7(9-10), pp. 312–8. doi: 10.5489/cuaj.1506.